SBIR/STTR Research Award

SBIR Phase I: A Platform for Penetrative Drug Delivery to Teeth

Award identifier 941b75584d7a91a8fc7b18e48f776b32d9ea1baf664f5386a5620fd39454ce1aAwarding agency National Science Foundation

Award amount

$275,000

Program and phase

SBIR · Phase I

Award year

2025

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Science Foundation
Branch
Not reported
Recipient company
T33 Dental, Inc.
Proposal award date
2025-01-13
Contract end date
2025-12-31
UEI
Q8HHVUDBSVZ9
Solicitation number
NSF 23-515
Topic code
MD

Research abstract

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is a novel medical device and dental approach for enabling rapid and more effective dental treatments by improving the permeability of pharmaceuticals and cosmetics into teeth. The system aims to augment the delivery of specific compounds for treating tooth decay resulting in over 175 million cavities drilled and filled and $45 billion costs per year in the US, with nearly 15 million requiring root canal therapy resulting in $15 billion costs to remove the underlying infection which topical or systemic antibiotics are unable to effectively treat. In the short term, the system aims to provide an augmentative method for the cosmetic dentistry market by improving teeth whitening treatments currently performed by nearly 80% of Americans, a $7 billion market when combining both the professional and over-the-counter whitening treatment markets. This Small Business Innovation Research (SBIR) Phase I project seeks to validate a novel device and approach for controlling electrically-mediated electrokinetic flow for enhancing the delivery of pharmaceuticals and cosmetics into whole human teeth. The novel system is based on experimental results demonstrating electrical voltage, current, time of application, pressure, with an additive for maintaining conductivity improves permeability of specific chemical formulations. These parameters will be validated on the speed and depth of delivery and their effects characterized using several commonly topically applied dental agents including fluoride and hydrogen peroxide bleach. Isolated invitro testing will then be completed to expand the potential for several relevant molecules including antimicrobial and regenerative agents. A prototype device will then be fabricated for enabling first in-human testing at a latter stage. The successful completion of this project therefore aims to demonstrate the technical feasibility of a

Technology keywords

Not reported

Agency intelligence

National Science Foundation

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.